Webinar: Strategies for HCV Testing and Linkage to Care in and from Prison

December 7th, 2018

Hepatitis C cannot be eliminated in the United States without reaching groups that are most impacted by the epidemic. Incarcerated or formerly incarcerated individuals bear a disproportionate burden of HCV with current estimates putting the prevalence in jails and prisons between 12 and 35 percent. Despite the high prevalence and recommendations from the Federal Bureau of Prisons (FBoP), the American Association for the Study of Liver Diseases (AASLD), and the Infectious Diseases Society of America (IDSA) to offer opt-out antibody testing (at the very least) to all incarcerated individuals, most inmates with chronic HCV are unaware of their status. Screening and linking individuals to care while incarcerated or upon release is essential to ensure they have access to a cure. NASTAD’s Hepatitis Testing Partnership and the National Hepatitis Corrections Network hosted a webinar exploring strategies for HCV testing and linkage to care for people currently in or transitioning from prison featuring examples from Philadelphia FIGHT, the Oregon Department of Corrections, and the Transitions Clinic Network.